These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 19447252)
1. Short neuroprotective peptides, ADNF9 and NAP, are structurally disordered and monomeric in PBS. Arakawa T; Niikura T; Arisaka F; Kita Y Int J Biol Macromol; 2009 Jul; 45(1):8-11. PubMed ID: 19447252 [TBL] [Abstract][Full Text] [Related]
2. Activity-dependent neurotrophic factor, ADNF, determines the structure characteristics of Colivelin, a fusion protein of ADNF9 and Humanin analog. Arakawa T; Niikura T; Arisaka F; Kita Y J Pept Sci; 2008 May; 14(5):631-6. PubMed ID: 17994638 [TBL] [Abstract][Full Text] [Related]
3. Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium. Arakawa T; Niikura T; Tajima H; Arisaka F; Kita Y J Mol Neurosci; 2007; 33(3):262-7. PubMed ID: 17952635 [TBL] [Abstract][Full Text] [Related]
4. The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, Humanin, by circular dichroism. Arakawa T; Niikura T; Tajima H; Kita Y J Pept Sci; 2006 Oct; 12(10):639-42. PubMed ID: 16835886 [TBL] [Abstract][Full Text] [Related]
5. The structure analysis of Humanin analog, AGA-(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule. Arisaka F; Niikura T; Arakawa T; Kita Y Int J Biol Macromol; 2008 Aug; 43(2):88-93. PubMed ID: 18456318 [TBL] [Abstract][Full Text] [Related]
6. NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function. Quintana FJ; Zaltzman R; Fernandez-Montesinos R; Herrera JL; Gozes I; Cohen IR; Pozo D Ann N Y Acad Sci; 2006 Jul; 1070():500-6. PubMed ID: 16888216 [TBL] [Abstract][Full Text] [Related]
8. The biological activity of Humanin analogs correlates with structure stabilities in solution. Arakawa T; Niikura T; Kita Y Int J Biol Macromol; 2011 Jul; 49(1):93-7. PubMed ID: 21510972 [TBL] [Abstract][Full Text] [Related]
9. Active form of neuroprotective Humanin, HN, and inactive analog, S7A-HN, are monomeric and disordered in aqueous phosphate solution at pH 6.0; No correlation of solution structure with activity. Arisaka F; Arakawa T; Niikura T; Kita Y Protein Pept Lett; 2009; 16(2):132-7. PubMed ID: 19200035 [TBL] [Abstract][Full Text] [Related]
10. AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders. Geerts H Curr Opin Investig Drugs; 2008 Jul; 9(7):800-11. PubMed ID: 18600585 [TBL] [Abstract][Full Text] [Related]
11. Stable right- and left-handed peptide helices containing C(alpha)-tetrasubstituted alpha-amino acids. Grauer AA; Cabrele C; Zabel M; König B J Org Chem; 2009 May; 74(10):3718-26. PubMed ID: 19354242 [TBL] [Abstract][Full Text] [Related]
12. Cationic oligopeptides with the repeating sequence L-lysyl-L-alanyl-L-alanine: conformational and thermal stability study using optical spectroscopic methods. Setnicka V; Hlavácek J; Urbanová M J Pept Sci; 2009 Aug; 15(8):533-9. PubMed ID: 19579212 [TBL] [Abstract][Full Text] [Related]
13. The microtubule interacting drug candidate NAP protects against kainic acid toxicity in a rat model of epilepsy. Zemlyak I; Manley N; Vulih-Shultzman I; Cutler AB; Graber K; Sapolsky RM; Gozes I J Neurochem; 2009 Dec; 111(5):1252-63. PubMed ID: 19799711 [TBL] [Abstract][Full Text] [Related]
14. Neurotrophic effects of the peptide NAP: a novel neuroprotective drug candidate. Gozes I; Spivak-Pohis I Curr Alzheimer Res; 2006 Jul; 3(3):197-9. PubMed ID: 16842095 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional structure of the two-peptide bacteriocin plantaricin JK. Rogne P; Haugen C; Fimland G; Nissen-Meyer J; Kristiansen PE Peptides; 2009 Sep; 30(9):1613-21. PubMed ID: 19538999 [TBL] [Abstract][Full Text] [Related]
16. Affinity-based screening of peptides recognizing assembly states of self-assembling peptide nanomaterials. Sawada T; Takahashi T; Mihara H J Am Chem Soc; 2009 Oct; 131(40):14434-41. PubMed ID: 19764764 [TBL] [Abstract][Full Text] [Related]
18. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers. Paule SG; Nikolovski B; Ludeman J; Gray RE; Spiccia L; Zimmet PZ; Myers MA Peptides; 2009 Jun; 30(6):1088-97. PubMed ID: 19463741 [TBL] [Abstract][Full Text] [Related]
19. Reversible self-assembly: a key feature for a new class of autodelivering therapeutic peptides. Pertinhez TA; Conti S; Ferrari E; Magliani W; Spisni A; Polonelli L Mol Pharm; 2009; 6(3):1036-9. PubMed ID: 19366260 [TBL] [Abstract][Full Text] [Related]
20. Peripheral nerve at extreme low temperatures 1: effects of temperature on the action potential. Stecker MM; Baylor K Cryobiology; 2009 Aug; 59(1):1-11. PubMed ID: 19558975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]